Cocaine Hepatotoxicity in Mice: Histologic and Enzymatic Studies

Toxicologic Pathology - Tập 19 Số 1 - Trang 24-29 - 1991
Sherif Z. Mehanny1, Mohamed S. Abdel‐Rahman1
1Department of Pharmacology/Toxicology, New Jersey Medical School UMDNJ, Newark, New Jersey 07103-2714

Tóm tắt

The severity of hepatotoxicity in CF-1 mice given 5 daily doses of 5, 10, and 20 mg cocaine/kg body weight and sacrificed 24 hr after the last injection appeared to be dose-dependent. Using light microscopy, the hallmark of cocaine early toxicity was manifested by pallor and ballooning of the hepatocytes in the midzonal and then in the centrilobular areas. Degeneration and necrosis of the liver cells in the same zones were encountered while the hepatocytes in the periportal areas remained intact. When examined under the electron microscope, such pallor and ballooning of the hepatocytes appeared to be due to dilation of the rough endoplasmic reticulum (RER) profiles which of ten revealed a significant loss of their ribosomes. Dilation of the smooth endoplasmic reticulum (SER) was also common and moderate proliferation of peroxisomes was frequently seen. In the degenerating hepatocytes, the 2 forms of endoplasmic reticulum were difficult to recognize and the peroxisomes appeared sparse. Cocaine treatment elevated the level of glutamic pyruvic transaminase and glutamic oxaloacetic transaminase in a dose-dependent manner. Although hepatic cytochrome P450 was slightly increased in the low dose groups, a reduction in the enzyme activity was noticed in the group treated with 20 mg cocaine/kg. However, hepatic reduced glutathione content manifested a significant increase in the group which received 20 mg cocaine/kg.

Từ khóa


Tài liệu tham khảo

10.1002/jcp.1030010205

10.1002/jbt.2570030407

10.1016/0003-2697(76)90527-3

Cook CE, 1985, Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs, 48

Duran BO, 1963, J. Lab. Clin. Med., 61, 882

10.1007/978-1-4684-3087-5_14

10.1016/0041-008X(78)90167-9

Evans MA, 1981, The Toxicologist, 1, 1

10.1016/0006-2952(81)90165-9

10.1007/BF01840652

10.1037/e496912006-007

10.1002/hep.1840060224

Kachmar JF, 1970, Fundamentals of Clinical Chemistry, 441

10.1016/0041-008X(82)90364-7

10.1016/S0031-3955(16)35005-2

10.1111/j.1360-0443.1967.tb05345.x

Mazel P, 1971, Fundamentals of Drug Metabolism and Drug Disposition, 527

10.1016/S0021-9258(20)82244-3

10.1016/0024-3205(82)90606-3

Raukman EJ, 1982, Mol. Pharmacol., 21, 458

10.1016/0024-3205(77)90291-0

10.1016/0006-2952(81)90630-4

10.1016/0006-2952(79)90705-6

Zar JH, 1984, Biostatistical Analysis, 2, 196